We are live on ! Find out more
BCV

Banque Cantonale Vaudoise Portfolio holdings

AUM $2.66B
1-Year Est. Return 26.89%
This Fund
S&P 500
This Quarter Est. Return
+9.69%
1 Year Est. Return
+26.89%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.46B
AUM Growth
–
Cap. Flow
+$1.39B
Cap. Flow %
95.36%
Top 10 Hldgs %
21.95%
Holding
899
New
896
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
UBS icon
UBS Group
UBS
+$54.4M
2
MSFT icon
Microsoft
MSFT
+$45.9M
3
AAPL icon
Apple
AAPL
+$37.3M
4
QQQ icon
Invesco QQQ Trust
QQQ
+$32M
5
AMZN icon
Amazon
AMZN
+$24.9M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 17.85%
2 Financials 14.78%
3 Healthcare 10.8%
4 Consumer Discretionary 10.73%
5 Communication Services 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DDD icon
876
3D Systems Corp
DDD
$430M
$24K ﹤0.01%
+2,693
New +$23.4K
RAVN
877
DELISTED
Raven Industries Inc
RAVN
$24K ﹤0.01%
+708
New +$24.2K
RES icon
878
RPC Inc
RES
$1.21B
$21K ﹤0.01%
+4,006
New +$18K
FRN
879
DELISTED
Invesco Frontier Markets ETF
FRN
$19K ﹤0.01%
+1,330
New +$18.8K
RSX
880
DELISTED
VanEck Russia ETF
RSX
$17K ﹤0.01%
+697
New +$16.9K
FLBR icon
881
Franklin FTSE Brazil ETF
FLBR
$539M
$12K ﹤0.01%
+395
New +$10.7K
VIVS
882
VivoSim Labs
VIVS
$1.34M
$12K ﹤0.01%
+139
New +$13K
PCG icon
883
PG&E
PCG
$47.1B
$10K ﹤0.01%
+900
New +$7.71K
IMVP
884
Invesco India ETF
IMVP
$124M
$9K ﹤0.01%
+458
New +$11.1K
BMY.RT
885
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$8K ﹤0.01%
+3,361
New +$8.74K
FCX icon
886
Freeport-McMoran
FCX
$90.1B
$7K ﹤0.01%
+500
New +$5.49K
WLK icon
887
Westlake Corp
WLK
$9.27B
$7K ﹤0.01%
+100
New +$6.72K
ASIX icon
888
AdvanSix
ASIX
$546M
$5K ﹤0.01%
+269
New +$5.88K
TEUM
889
DELISTED
Pareteum Corporation
TEUM
$3K ﹤0.01%
+6,490
New +$3.75K
CRC
890
DELISTED
California Resources Corporation
CRC
$3K ﹤0.01%
+297
New +$2.41K
OBSV
891
DELISTED
ObsEva SA Ordinary Shares
OBSV
$1K ﹤0.01%
+241
New +$1.25K
ABEO icon
892
Abeona Therapeutics
ABEO
$349M
– –
0
– –
ACHV icon
893
Achieve Life Sciences
ACHV
$634M
– –
0
– –
ALTO icon
894
Alto Ingredients
ALTO
$348M
$0 ﹤0.01%
+1
New +$1
BTG icon
895
B2Gold
BTG
$5.16B
$0 ﹤0.01%
+1
New +$4
FURY
896
Fury Gold Mines
FURY
$103M
$0 ﹤0.01%
+4
New +$8
INO icon
897
Inovio Pharmaceuticals
INO
$79.4M
– –
0
– –
LEU icon
898
Centrus Energy
LEU
$3.47B
$0 ﹤0.01%
+4
New +$23
GCVRZ
899
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$0 ﹤0.01%
+112
New +$86
32 33 34 35
36

Similar funds

ACIM
Azimuth Capital Investment Management Bloomfield Hills, Michigan $2.66B AUM 22.87% 1-Year Est. Return
PCA
Pallas Capital Advisors Braintree, Massachusetts $2.66B AUM 22.31% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $2.65B AUM 79.03% 1-Year Est. Return
CCM
Cerberus Capital Management New York $2.65B AUM 20.18% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return

Banque Cantonale Vaudoise's Q4 2019 Portfolio in Review

Q4 2019 is the first quarter with a 13F filing on record for Banque Cantonale Vaudoise, which disclosed 899 positions worth $1.46B. Its ten largest holdings account for 22% of the portfolio.

Its largest position is UBS Group: 4,575,321 shares worth $57.8M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, followed by Financials and Healthcare.

  • Banque Cantonale Vaudoise's largest Q4 2019 buy was UBS Group: 4,575,321 shares worth $57.8M.
  • Banque Cantonale Vaudoise's ten largest holdings make up 22% of its $1.46B portfolio in Q4 2019.
  • Banque Cantonale Vaudoise disclosed 899 positions in Q4 2019, its first 13F filing on record.

Based on Banque Cantonale Vaudoise's 13F filing for Q4 2019, filed 10 Feb 2020.